Ran Nussbaum Insider Trading $ELOX Eloxx Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ran Nussbaum.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ran Nussbaum. Ran Nussbaum is Director in ARQULE INC ($ARQL) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Kite Pharma, Inc. ($KITE) and Director in Keros Therapeutics, Inc. ($KROS) and Director in UroGen Pharma Ltd. ($URGN) and Director in Prevail Therapeutics Inc. ($PRVL).

Ran Nussbaum in Eloxx Pharmaceuticals, Inc.

Trading Symbol: ELOX
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Ran Nussbaum: Director
Holdings: 1,791,470 shares
Current Value: $412,038
Latest Transaction: May 17 2021
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Ran Nussbaum in Eloxx Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARQL, ELOX, KROS, KITE, PRVL, URGN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 17 2021	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	1.35	592,592	799,999	616,592	24 K to 616.6 K (+2,469.13 %)
May 17 2021	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	1.35	1,422,222	1,920,000	1,989,551	567.3 K to 2 M (+250.69 %)
May 17 2021	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	1.35	2,630,487	3,551,157	3,679,797	1 M to 3.7 M (+250.69 %)
May 17 2021	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	1.35	1,280,624	1,728,842	1,791,470	510.8 K to 1.8 M (+250.69 %)
Jun 26 2019	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.00	24,000	216,000	24,000	0 to 24 K
Jun 26 2019	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.00	46,933	422,397	567,329	520.4 K to 567.3 K (+9.02 %)
Jun 26 2019	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.00	86,806	781,254	1,049,310	962.5 K to 1 M (+9.02 %)
Jun 26 2019	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.00	42,261	380,349	510,846	468.6 K to 510.8 K (+9.02 %)
May 29 2019	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran		Option Exercise	A	9.02	20,000	180,400	20,000
Jun 19 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Option Exercise	A	23.27	40,000	930,800	40,000
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.75	93,333	909,997	520,396	427.1 K to 520.4 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.75	172,626	1,683,104	962,504	789.9 K to 962.5 K (+21.85 %)
May 01 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	9.75	84,041	819,400	468,585	384.5 K to 468.6 K (+21.85 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	8.00	1,600	12,800	427,063	425.5 K to 427.1 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	8.00	2,959	23,672	789,878	786.9 K to 789.9 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	8.00	1,441	11,528	384,544	383.1 K to 384.5 K (+0.38 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	7.55	1,760	13,288	425,463	423.7 K to 425.5 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	7.55	3,255	24,575	786,919	783.7 K to 786.9 K (+0.42 %)
Mar 23 2018	ELOX	Eloxx Pharmaceutic ...	Nussbaum Ran	Director	Buy	P	7.55	1,585	11,967	383,103	381.5 K to 383.1 K (+0.42 %)

Page: 1